OpenAI is partnering with Los Alamos National Laboratory (LANL), which produced the world's first nuclear weapon, to trial the use of AI in bioscience research. OpenAI said it was working with the lab's bioscience division to evaluate how AI models, specifically GPT-4o, could assist scientists in performing tasks in a physical laboratory. LANL's bioscience department works in a wide range of research areas, including vaccine development, sustainable biotechnology, the impact of climate change on disease emergence, and various biothreat detections.

OpenAI said the upcoming partnership will expand on its previous bioscience work in two key dimensions, including the incorporation of "wet lab techniques" that involve training models to help perform more complex tasks. Additionally, the AI ​​company said GPT-4o's audio and visual input will focus on new "modalities" of using AI in the laboratory environment to open new channels with the potential to "accelerate learning" among scientists.

The new partnership comes as major tech companies — including Microsoft and Apple — begin to distance themselves from the AI ​​startup amid growing regulatory concerns. A year after Microsoft invested in OpenAI, it announced its decision to withdraw from OpenAI. European Union regulators have announced that OpenAI may face an EU antitrust investigation over its partnership with Microsoft.

What do you think about this? We are waiting your comments.#OpenAI#AI#Bioscience#Research